Implementation of personalized medicine in a context of moral hazard and uncertainty about treatment efficacy
Year of publication: |
2021
|
---|---|
Authors: | Alcenat, Stéphane ; Maréchal, François ; Naegelen, Florence |
Subject: | Genetic information | Healthcare | Moral hazard | Optimal contracts | Personalized medicine | Pharmacoeconomics | Moral Hazard | Arzneimittel | Pharmaceuticals | Theorie | Theory | Medizinische Behandlung | Medical treatment | Prinzipal-Agent-Theorie | Agency theory | Krankenversicherung | Health insurance | Gesundheitsversorgung | Health care | Risiko | Risk |
-
Contracts to promote optimal use of optional diagnostic tests in cancer treatment
Ghamat, Salar, (2018)
-
Outcomes-based reimbursement policies for chronic care pathways
Zorc, Sasa, (2017)
-
Outcomes-based reimbursement policies for chronic care pathways
Zorc, Sasa, (2023)
- More ...
-
Tests génétiques prédictifs et marchés de l'assurance santé
Alcenat, Stéphane, (2019)
-
The impact of medical complications on optimal hospital payment
Maréchal, François, (2021)
-
What Allotment and Subcontracting in Procurement Bidding
MARÉCHAL, François, (2004)
- More ...